↓ Skip to main content

Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug

Overview of attention for article published in Cardiovascular Diabetology, May 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
41 X users

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
91 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug
Published in
Cardiovascular Diabetology, May 2021
DOI 10.1186/s12933-021-01294-7
Pubmed ID
Authors

Lorenzo Nesti, Domenico Tricò, Alessandro Mengozzi, Andrea Natali

X Demographics

X Demographics

The data shown below were collected from the profiles of 41 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 91 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 8%
Student > Bachelor 7 8%
Student > Postgraduate 5 5%
Professor > Associate Professor 5 5%
Student > Master 5 5%
Other 13 14%
Unknown 49 54%
Readers by discipline Count As %
Medicine and Dentistry 15 16%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Biochemistry, Genetics and Molecular Biology 5 5%
Nursing and Health Professions 2 2%
Agricultural and Biological Sciences 2 2%
Other 5 5%
Unknown 57 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2023.
All research outputs
#1,659,053
of 25,732,188 outputs
Outputs from Cardiovascular Diabetology
#96
of 1,688 outputs
Outputs of similar age
#42,408
of 458,814 outputs
Outputs of similar age from Cardiovascular Diabetology
#5
of 37 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,688 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 458,814 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.